These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10144942)

  • 41. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN; Ferrari PL; Murphy AM;
    Food Drug Law J; 2003; 58(3):331-45. PubMed ID: 14626233
    [No Abstract]   [Full Text] [Related]  

  • 42. Kiss and make-up: a need for consolidation of FDA and cosmetic industry regulation programs.
    Mason DE
    Health Matrix Clevel; 2008; 18(1):181-207. PubMed ID: 19161130
    [No Abstract]   [Full Text] [Related]  

  • 43. Medical gas mix-up implicated in patient death.
    Segal M; Foulke J
    FDA Consum; 1992 Mar; 26(2):40-1. PubMed ID: 10117480
    [No Abstract]   [Full Text] [Related]  

  • 44. The Food and Drug Administration's evolving regulation of press releases: limits and challenges.
    Vodra WW; Cortez NG; Korn DE
    Food Drug Law J; 2006; 61(4):623-51. PubMed ID: 17180767
    [No Abstract]   [Full Text] [Related]  

  • 45. Are dentists not doctors, also?
    Ring ME
    N Y State Dent J; 1994 Dec; 60(10):10-1. PubMed ID: 7824220
    [No Abstract]   [Full Text] [Related]  

  • 46. NRC proposed amendments: too little, too late?
    Newman MA
    J Nucl Med; 1993 Sep; 34(9):25N. PubMed ID: 8355088
    [No Abstract]   [Full Text] [Related]  

  • 47. Amendment of regulations regarding certain label statements on prescription drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Feb; 67(22):4904-7. PubMed ID: 11829025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Legal strategies to address the misrepresentation of Vermont maple syrup.
    Gold HD
    Food Drug Law J; 2004; 59(1):93-132. PubMed ID: 15190927
    [No Abstract]   [Full Text] [Related]  

  • 49. New rules will standardize labeling for dietary supplements.
    Am J Health Syst Pharm; 1997 Nov; 54(22):2561. PubMed ID: 9397216
    [No Abstract]   [Full Text] [Related]  

  • 50. Dietary supplements of botanicals and other substances: a new era of regulation.
    McNamara SH
    Food Drug Law J; 1995; 50(3):341-8. PubMed ID: 10343003
    [No Abstract]   [Full Text] [Related]  

  • 51. The case for a substantial evidence amendment to the informal rulemaking provision of the Federal Food, Drug, and Cosmetic Act.
    Bachrach EE
    Food Drug Law J; 2000; 55(3):293-9. PubMed ID: 11824461
    [No Abstract]   [Full Text] [Related]  

  • 52. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 53. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(231):66631-72. PubMed ID: 10338880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. It takes many hands to finally solve a glutaraldehyde safety problem.
    McCormack J
    Mater Manag Health Care; 1995 Dec; 4(12):32, 34, 36. PubMed ID: 10153414
    [No Abstract]   [Full Text] [Related]  

  • 55. The WLF case thus far: not with a bang, but a whimper.
    Cooper RM
    Food Drug Law J; 2000; 55(4):477-89. PubMed ID: 12025847
    [No Abstract]   [Full Text] [Related]  

  • 56. Environmental control of glutaraldehyde.
    Campbell M; Cripps NF
    Health Estate J; 1991 Nov; 45(9):2-6. PubMed ID: 10115741
    [No Abstract]   [Full Text] [Related]  

  • 57. Package insert of shunt closure devices, for the doctor or for the lawyer?
    Meier B
    Catheter Cardiovasc Interv; 2009 May; 73(6):827. PubMed ID: 19367650
    [No Abstract]   [Full Text] [Related]  

  • 58. Modification and consumer information: modern biotechnology and the regulation of information.
    Beales JH
    Food Drug Law J; 2000; 55(1):105-17. PubMed ID: 12322718
    [No Abstract]   [Full Text] [Related]  

  • 59. First Amendment limits on regulating information: an initial reaction to the Washington Legal Foundation case.
    Gibbs JN
    Food Drug Law J; 1998; 53(4):597-601. PubMed ID: 10557578
    [No Abstract]   [Full Text] [Related]  

  • 60. Legal overview of likely FDA regulation of Internet promotion.
    Scheineson MJ
    Food Drug Law J; 1996; 51(4):697-716. PubMed ID: 11797736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.